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Objectives: HLA-B*13:50 and -B*51:39 are two low incidence alleles in the HLA-B locus. The objective of
this study is to report the deduced probable human leukocyte antigen (HLA) haplotypes in association
with HLA-B*13:50 and -B*51:39 in Taiwanese unrelated bone marrow hematopoietic stem cell donors.
Materials and Methods: A sequence-based typing method was used to conﬁrm the two low incidence
alleles observed. Polymerase chain reaction was performed to amplify exons 2 and 3 in the HLA-A and
HLA-B loci and exon 2 in the HLA-DRB1 locus with group-speciﬁc primer sets. Amplicons were
sequenced using the BigDye Terminator Cycle Sequencing Ready Reaction Kit in both directions ac-
cording to the manufacturer’s protocols.
Results: The DNA sequence of B*13:50 is identical to B*13:01:01 in exons 2 and 3, except for a one
nucleotide substitution at residue 482 (A/T), which results in a one amino acid replacement at position
137 (aspartic acid/valine). We deduced the probable HLA haplotype in association with B*13:50 in
Taiwanese as A*11:02-B*13:50-DRB1*07:01. The DNA sequence of B*51:39 is identical to B*51:01:03 in
exons 2 and 3 except for two nucleotide exchanges at residue 226 (A/G) and residue 228 (A/G), which
result in a one amino acid substitution at position 52 (isoleucine/valine).The probable HLA haplotypes
associated with B*51:39 in Taiwanese may be deduced as A*02-B*51:39-DRB1*15 and A*11-B*51:39-
DRB1*15.
Conclusion: Information on the deduced HLA haplotypes in association with the low incidence B*13:50
and B*51:39 alleles that we report here is valuable for HLA testing laboratories for reference purposes
and for stem cell transplantation donor search coordinators, to determine the likelihood of ﬁnding
compatible donors in unrelated bone marrow donor registries for patients carrying these two uncom-
mon HLA alleles.
Copyright  2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
The continuing discovery of new human leukocyte antigen
(HLA) alleles and recognition HLA low incidence alleles has
enriched our understanding of the complexity of the HLA system.lls Centre, Buddhist Tzu Chi
Hualien, Taiwan. Tel.: þ886
g).
elief Tzu Chi Foundation. PublisheThemajor histocompatibility complex (MHC) in humans consists of
several loci of genes located on the short arm of chromosome 6 at
6p21.3. These loci are classiﬁed into Class I, II, and III of the MHC.
The genes of HLA alleles are located in the MHC Class I and II re-
gions. The HLA genes are characterized by their extreme allelic
polymorphism and their variations and diversity among different
ethnic groups and racial populations. HLA molecules have been
deﬁnitely deﬁned as transplant antigens with strong relevance in
tissue transplantation, and their molecule similarity between do-
nors and recipients is being considered as a prediction factor for
graft survival and graft versus host disease. It is imperative tod by Elsevier Taiwan LLC. All rights reserved.
K.-L. Yang et al. / Tzu Chi Medical Journal 26 (2014) 68e72 69precisely characterize any new and low incidence alleles encoun-
tered during routine HLA typing procedures. To facilitate successful
and comprehensive unrelated bone marrow donor searches for
patients in need of hematopoietic stem cell transplantation,
persistent effort is needed to resolve unidentiﬁed, ambiguous or
low incidence alleles in order to offer better services for HLA
matching and donor selection.
HLA-B*13:50 and HLA-B*51:39 were ﬁrst reported to the In-
ternational ImMunoGeneTics/HLA (IMGT/HLA) database in 2011
and 2013 (Cell ID HC4927 and Cell ID HC27439) and 2005 (Cell ID
HC13952), respectively [1]. Here, we report the deduced probable
HLA haplotypes in association with B*13:50 and B*51:39. We
further postulate that there are two plausible HLA haplotypes inA  
B 
cDNA                       10         20         30         40       
 B*13:01:01         ATGCGGGTCA CGGCGCCCCG AACCCTCCTC CTGCTGCTCT GGGG
 B*13:50            ********** ********** ********** ********** ****
  
 cDNA                      110        120        130        140      
 B*13:01:01         CCGCCATGTC CCGGCCCGGC CGCGGGGAGC CCCGCTTCAT CACC
 B*13:50            ---------- ---------- ---------- ---------- ----
  
 cDNA                      210        220        230        240      
 B*13:01:01         GAGGATGGCG CCCCGGGCGC CATGGATAGA GCAGGAGGGG CCGG
 B*13:50            ---------- ---------- ---------- ---------- ----
  
 cDNA                      310        320        330        340      
 B*13:01:01         AACCTGCGCA CCGCGCTCCG CTACTACAAC CAGAGCGAGG CCG|
 B*13:50            ---------- ---------- ---------- ---------- ---|
  
 cDNA                      410        420        430        440      
 B*13:01:01         TCCGCGGGCA TAACCAGTTA GCCTACGACG GCAAGGATTA CATC
 B*13:50            ---------- ---------- ---------- ---------- ----
  
 cDNA                      510        520        530        540      
 B*13:01:01         CCAGCTCAAG TGGGAGGCGG CCCGTGTGGC GGAGCAGCTG AGAG
 B*13:50            ---------- ---------- ---------- ---------- ----
  
 cDNA                      610         620        630        640     
 B*13:01:01         GAGACGCTGC AGCGCGCGG|A CCCCCCAAAG ACACACGTGA CCC
 B*13:50            ---------- ---------|- ---------- ---------- ---
Fig. 1. (A) The raw sequence data (forward and reverse strains) show that at residue 482,
sequence of B*13:50 is identical to B*13:01:01 in exons 2 and 3, except for a one nucleotidassociation with B*51:39 in Taiwanese and that the haplotypes
associated with B*13:50 and B*51:39 are restricted to Asians.
2. Materials and methods
Peripheral whole blood samples from unrelated bone marrow
stem cell donors with Taiwanese ethnicity were collected in acid
citrate dextrose anticoagulant. Formal written consents were
signed by the donors before blood collection. The acid citrate
dextrose whole blood samples were stored at e80C until use.
Genomic DNAwas extracted using the QIAamp DNA Blood Mini Kit
according to the manufacturer’s instructions (Qiagen, Hilden, Ger-
many). The DNA material was subjected to HLA genotyping for  50         60         70          80         90        100  
GGCAGT GGCCCTGACC GAGACCTGGG CCG|GCTCCCA CTCCATGAGG TATTTCTACA  
****** ********** ********** ***|------- ---------- ----------  
  150        160        170        180        190        200  
GTGGGC TACGTGGACG ACACCCAGTT CGTGAGGTTC GACAGCGACG CCACGAGTCC  
------ ---------- ---------- ---------- ---------- ----------  
  250        260        270        280        290        300  
AGTATT GGGACCGGGA GACACAGATC TCCAAGACCA ACACACAGAC TTACCGAGAG  
------ ---------- ---------- ---------- ---------- ----------  
   350        360        370        380        390        400  
GGTCTCA CATCATCCAG AGGATGTATG GCTGCGACCT GGGGCCGGAC GGGCGCCTCC  
------- ---------- ---------- ---------- ---------- ----------  
  450        460        470        480        490        500  
GCCCTG AACGAGGACC TGAGCTCCTG GACCGCGGCG GACACCGCGG CTCAGATCAC  
------ ---------- ---------- ---------- -T-------- ----------  
  550        560        570        580        590        600  
CCTACC TGGAGGGCGA GTGCGTGGAG TGGCTCCGCA GATACCTGGA GAACGGGAAG  
------ ---------- ---------- ---------- ---------- ----------  
   650        660        670        680        690        700  
ACCACCC CATCTCTGAC CATGAGGCCA CCCTGAGGTG CTGGGCCCTG GGCTTCTACC  
------- ---------- ---------- ---------- ---------- ----------  
the nucleotide A of B*13:01:01 is replaced by the T (in red) of B*13:50; (B) the DNA
e substitution at residue 482 (A/T) (shaded).
AA Pos.                    10         20         30         40         50         60         70         80         90        100  
 B*13:01:01         GSHSMRYFYT AMSRPGRGEP RFITVGYVDD TQFVRFDSDA TSPRMAPRAP WIEQEGPEYW DRETQISKTN TQTYRENLRT ALRYYNQSEA GSHIIQRMYG  
 B*13:50            *--------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------  
 AA Pos.                   110        120        130        140        150        160        170        180        190        200  
 B*13:01:01         CDLGPDGRLL RGHNQLAYDG KDYIALNEDL SSWTAADTAA QITQLKWEAA RVAEQLRAYL EGECVEWLRR YLENGKETLQ RADPPKTHVT HHPISDHEAT  
 B*13:50            ---------- ---------- ---------- ------V--- ---------- ---------- ---------- ---------- ---------- ----------  
 AA Pos.                   210        220        230        240        250        260        270      
 B*13:01:01         LRCWALGFYP AEITLTWQRD GEDQTQDTEL VETRPAGDRT FQKWAAVVVP SGEEQRYTCH VQHEGLPKPL TLRW 
 B*13:50            ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---- 
Fig. 2. The nucleotide substitution of B*13:50 from B*13:01:01 causes an amino acid replacement at residue 137 (aspartic acid/valine) (shaded).
K.-L. Yang et al. / Tzu Chi Medical Journal 26 (2014) 68e7270HLA-A, -B and -DRB1 loci using commercial polymerase chain
reaction-sequencing based typing kits, SeCore A/B/DRB1 Locus
Sequencing Kits (Life Technologies, Brown Deer, WI, USA). High
resolution allelic sequencing was performed as previously
described [2e6]. The two sets of primer sequences used were: (1)cDNA                       80         90        100        110       
 B*51:01:03            GCTCCCA CTCCATGAGG TATTTCTACA CCGCCATGTC CCGG
 B*51:39               ------- ---------- ---------- ---------- ----
 cDNA                      180        190        200        210      
 B*51:01:03         CGTGAGGTTC GACAGCGACG CCGCGAGTCC GAGGACGGAG CCCC
 B*51:39            ---------- ---------- ---------- ---------- ----
 cDNA                      280        290        300        310      
 B*51:01:03         TTCAAGACCA ACACACAGAC TTACCGAGAG AACCTGCGGA TCGC
 B*51:39            ---------- ---------- ---------- ---------- ----
 cDNA                      380        390        400        410      
 B*51:01:03         GCTGCGACGT GGGGCCGGAC GGGCGCCTCC TCCGCGGGCA TAAC
 B*51:39            ---------- ---------- ---------- ---------- ----
 cDNA                      480        490        500        510      
 B*51:01:03         GACCGCGGCG GACACCGCGG CTCAGATCAC CCAGCGCAAG TGGG
 B*51:39            ---------- ---------- ---------- ---------- ----
 cDNA                      580        590        600        610  
 B*51:01:03         TGGCTCCGCA GACACCTGGA GAACGGGAAG GAGACGCTGC AGCG
 B*51:39            ---------- ---------- ---------- ---------- ----
A
B
Fig. 3. (A) The raw sequence data (forward and reverse strains) show that at residues 226 an
the DNA sequence of B*51:39 is identical to B*51:01:03 in exons 2 and 3 except for two nuB-CG: M13-BIN1-CGG (sense): TgTAAAACgACggCCAgTCgggggCg
CAggACCCgg; P30exon 5B (anti-sense): gCTCCgATgACCACAACTgCT;
and (2) B-TA: M13-BIN1-TGA (sense): TgTAAAACgACggCCAgTgg
CgggggCgCAggACCTgA; P30exon 5B (anti-sense): gCTCCgATgACCA
CAACTgCT. The amplicons were sequenced by the BigDye 120        130        140        150        160        170  
CCCGGC CGCGGGGAGC CCCGCTTCAT TGCAGTGGGC TACGTGGACG ACACCCAGTT  
------ ---------- ---------- ---------- ---------- ----------  
  220        230        240        250        260        270  
GGGCGC CGTGGATAGA GCAGGAGGGG CCGGAGTATT GGGACCGGAA CACACAGATC  
------ -----G-G-- ---------- ---------- ---------- ----------  
  320        330        340         350        360        370  
GCTCCG CTACTACAAC CAGAGCGAGG CCG|GGTCTCA CACTTGGCAG ACGATGTATG  
------ ---------- ---------- ---|------- ---------- ----------  
  420        430        440        450        460        470  
CAGTAC GCCTACGACG GCAAAGATTA CATCGCCCTG AACGAGGACC TGAGCTCCTG  
------ ---------- ---------- ---------- ---------- ----------  
  520        530        540        550        560        570  
AGGCGG CCCGTGAGGC GGAGCAGCTG AGAGCCTACC TGGAGGGCCT GTGCGTGGAG  
------ ---------- ---------- ---------- ---------- ----------  
CGCGG       
-----       
d 228, the nucleotides A of B*51:01:03 are replaced by the R (A in green) of B*51:39; (B)
cleotide exchanges at residue 226 (A/G) (shaded) and residue 228 (A/G) (shaded).
AA Pos.                    10         20         30         40         50         60         70         80         90        100  
 B*51:01:03         *SHSMRYFYT AMSRPGRGEP RFIAVGYVDD TQFVRFDSDA ASPRTEPRAP WIEQEGPEYW DRNTQIFKTN TQTYRENLRI ALRYYNQSEA GSHTWQTMYG  
 B*51:39            *--------- ---------- ---------- ---------- ---------- -V-------- ---------- ---------- ---------- ----------  
 AA Pos.                   110        120        130        140        150        160        170        180         
 B*51:01:03         CDVGPDGRLL RGHNQYAYDG KDYIALNEDL SSWTAADTAA QITQRKWEAA REAEQLRAYL EGLCVEWLRR HLENGKETLQ RA 
 B*51:39            ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- --  
Fig. 4. The nucleotide substitutions of B*51:39 from B*51:01:03 cause an amino acid replacement at residue 52 (isoleucine/valine) (shaded).
Table 1
HLA-A, -B, and -DRB1* alleles of donors with B*51:39 and the deduced probable HLA-A-B-DRB1 haplotype associated with B*51:39.
Donor HLA-A* HLA-B* HLA-DRB1* Deduced probable HLA-A-B-DRB1 haplotype
Donor 1 02:06 02:07 46:01 51:39 09:01 15:01 A*02-B*51:39-DRB1*15
Donor 2 02 11 15 51:39 15 15 A*02-B*51:39-DRB1*15 or A*11-B*51:39-DRB1*15
Donor 3 02:03 d 46 51:39 12 15 A*02-B*51:39-DRB1*15
Donor 4 02:06 02:07 46:01 51:39 11:01 15:01 A*02-B*51:39-DRB1*15
Donor 5 11:02 33:03 46 51:39 09:01 15:01 A*11-B*51:39-DRB1*15
Donor 6 02:06 24:02 40 51:39 12:02 15 A*02-B*51:39-DRB1*15
Donor 7 02:01 02:06 40 51:39 11 15 A*02-B*51:39-DRB1*15
Donor 8 02 02 46 51:39 11 15 A*02-B*51:39-DRB1*15
Donor 9 02 02 15 51:39 11 15 A*02-B*51:39-DRB1*15
Donor 10 02 26 39 51:39 08 15 A*02-B*51:39-DRB1*15
Donor 11 01 11 37 51:39 10 15 A*11-B*51:39-DRB1*15
Donor 12 02 11 40 51:39 15:01 15:01 A*02-B*51:39-DRB1*15 or A*11-B*51:39-DRB1*15
K.-L. Yang et al. / Tzu Chi Medical Journal 26 (2014) 68e72 71Terminator Cycle Sequencing Ready Reaction Kit (Applied Bio-
systems, Foster City, CA, USA) in both directions.
3. Results
We conﬁrmed the DNA sequence of B*13:50 was identical to
B*13:01:01 in exons 2 and 3, except for a one nucleotide substitu-
tion at residue 482 (A/T) (Fig.1), which results in a one amino acid
replacement at amino acid position 137 (aspartic acid/valine)
(Fig. 2). The extended HLA-A, -B and -DRB1 typing of our donor
with B*13:50 was A*11:02, A*68:01, B*13:50, B*52:01, DRB1*07:01,
and DRB1*09:01. Based on HLA linkage disequilibria in the Asian
population [7], we deduced the probable HLA haplotype in asso-
ciation with B*13:50 in our Taiwanese donor as A*11:02-B*13:50-
DRB1*07:01. We conﬁrmed that the DNA sequence of B*51:39
was identical to B*51:01:03 in exons 2 and 3, except for two
nucleotide exchanges at residue 226 (A/G) and residue 228
(A/G) (Fig. 3). The DNA substitutions result in a one amino acid
replacement at position 52 (isoleucine/valine) (Fig. 4). In our
unrelated marrow stem cell donor registry’s database, we have 12
donors carrying B*51:39. The extended HLA typings of the 12 do-
nors carrying B*51:39 are shown in Table 1. Taken together, the two
HLA-A, -B and -DRB1 haplotypes associated with B*51:39 in
Taiwanese donors may be deduced as A*02-B*51:39-DRB1*15 and
A*11-B*51:39-DRB1*15.
4. Discussion
We conﬁrmed the DNA sequences and amino acid sequences of
two low frequency HLA alleles, B*13:50 and B*51:39, in this study.
B*13:50 was initially detected in an individual (with HLA typing of
A*02:07, A*11:02, B*13:50, B*46:01, DRB1*09:01, and DRB1*15:01)
in Singapore [8]. Based on the known haplotype frequencies of HLA
in the Chinese population and excluding the commonly observed
haplotype A*02:07-B*46:01-DRB1*09:01 by linkage disequilib-
rium, a probable HLA haplotype in association with B*13:50 was
deduced as A*11:02-B*13:50-DRB1*15:01 [8]. This haplotype dif-
fers from the B*13:50 haplotype (A*11:02-B*13:50-DRB1*07:01)
that we deduced in this study. Our deduction is based on the known
haplotype frequency in the Asian population [7] and by eliminating
the commonly observed probable haplotype of A*68:01-B*52:01-DRB1*09:01 in our donor. B*51:39 was ﬁrst detected in a donor
from Singapore with HLA-A*02, A*11, B*27:04, B*51:39,
DRB1*12:02, and DRB1*15:02 alleles [9]. Two probable B*51:39
-associated HLA haplotypes may be deduced from the Singapore
blood donor as A*02-B*51:39-DRB1*15:02 and A*11-B*51:39-
DRB1*15:02. In agreement, we deduced two identical most prob-
able B*51:39 -associated HLA haplotypes from our unrelated bone
marrow donors as shown in Table 1. Taken together from the
Singapore [9] and Taiwanese individuals bearing B*51:39, we may
further speculate that B*51:39 is strongly associated with DRB1*15.
Since B*13:50 and B*51:39 have been detected only in donors from
Singapore and Taiwan, we think that these two low incidence HLA
alleles and their associated haplotypes may be restricted to the
Asian population. Determining the ethnicity of B*13:50 and
B*51:39 and their linked HLA haplotypes is signiﬁcant, because the
information may be employed in anthropological investigations of
races, in addition to allowing search coordinators in unrelated bone
marrow donor registries to allocate appropriate unrelated bone
marrow hematopoietic stem cell donors for their patients.
It is worth mentioning that the classic and most direct method
of determining HLA haplotypes is through family study, if test
materials for a number of key family members are available.
Alternatively, a population study may be employed if a signiﬁcant
number of unrelated donors is available [10]. However, the haplo-
types deduced via population investigation are considered as likely
or most probable. In this study, because of the availability of the
necessary test material from the families, we opted to determine
the haplotypes by looking at the HLA alleles carried in common by
unrelated donors bearing the same alleles of interest. In addition, if
determination of plausible HLA haplotypes is for rare or low fre-
quency HLA alleles, the alleles shared in common by unrelated
individuals may be employed to deduce the associated probable
haplotypes [11e18]. According to our HLA typing practice and Allele
Frequencies in World Populations (http://www.allelefrequencies.
net/hla6006a.asp?hla_locus_type¼Classical#), the frequencies of
B*13:50 and B*51:39 in Taiwanese are extremely low, at about 1 in
20,000. Therefore, we think the probable B*13:50 and B*51:39 in
the Taiwanese-associated haplotypes that we deduced in this study
are highly likely. The number of HLA alleles is exponentially
increasing with the recent development of DNA-based molecular
typing technology. HLA diversity in ethnic groups is unique and
K.-L. Yang et al. / Tzu Chi Medical Journal 26 (2014) 68e7272important. Facilitating an appropriate HLA-matched unrelated
bonemarrow stem cell donor for a given patient for successful stem
cell transplantations relies on the accuracy of HLA typing and the
spirit and strength to resolve unknown, ambiguous and low inci-
dence genes in the HLA system. Our challenge is enormous and
rewarding.
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